Announced Mon, 15 Jun · 11:43 IST
Board to meet on June 18 to consider director appointment, auditor and share transfer
Management Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+12.9%1-day move
₹1.70
prior close
₹1.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+12.9+9.4+4.1+8.8+15.9+17.6+17.1+4.1——
Up moveDown movePending
AI summary
Vivanza Biosciences' Board meets on June 18, 2026 to: (1) authorise Mr. Sarang Pathak to sign FY ended March 2026 financial statements; (2) appoint M/s. Dharti Shah & Co. as Internal Auditor for FY2026-27; (3) appoint Mr. Hemant Parikh as Non-Executive Non-Independent Director; and (4) transfer certain unverified shares to the Unclaimed Suspense Account pending KYC verification.
Likely market impact
Routine governance and housekeeping items; new director and internal auditor appointments signal steady board strengthening, with no material price-moving triggers.